New Products & Services

Article

Raritan, NJ-The FDA has approved a once-a-day liquid formulation of the fluoroquinone antibiotic levofloxacin (Levaquin), from Ortho-McNeil Pharmaceutical, Inc. Levofloxacin is indicated for the treatment of a number of infections, including complicated and uncomplicated urinary tract infections, chronic bacterial prostatitis, and acute pyelonephritis.

Related Videos
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Randall A. Lee, MD, answers a question during a Zoom video interview
doctor's hands holding a patient's hand
Martha Boone, MD, answers a question during a Zoom video interview
Dr. Nikita R. Bhatt in an interview with Urology Times
Female patient listening to doctor | Image Credit: © Konstantin Yuganov - stock.adobe.com
Woman writing in a notebook | Image Credit: © Baramee - stock.adobe.com
© 2023 MJH Life Sciences

All rights reserved.